Hansoh Pharma
Hansoh Pharmaceutical Group Company Limited, commonly known as Hansoh Pharma, is a leading biopharmaceutical enterprise headquartered in China. Established in 1995, the company has made significant strides in the pharmaceutical industry, focusing on the research, development, manufacturing, and marketing of innovative medicines. With a strong presence in major operational regions across Asia and beyond, Hansoh Pharma is dedicated to addressing unmet medical needs. The company’s core business areas include oncology, central nervous system disorders, and autoimmune diseases, with a portfolio of unique products that leverage advanced biopharmaceutical technologies. Notably, Hansoh Pharma has achieved recognition for its commitment to quality and innovation, positioning itself as a key player in the global market. With numerous accolades and a robust pipeline of therapies, Hansoh Pharma continues to contribute to the advancement of healthcare solutions.
DitchCarbon Score
How does Hansoh Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hansoh Pharma's score of 10 is lower than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hansoh Pharma's reported carbon emissions
Hansoh Pharma, headquartered in China (CN), currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of data suggests that Hansoh Pharma may still be in the early stages of formalising its climate commitments or reporting on its carbon footprint. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Hansoh Pharma to establish clear emissions reduction strategies and targets to align with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hansoh Pharma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
